The Inhibitory HVEM-BTLA Pathway Counter Regulates Lymphotoxin β Receptor Signaling to Achieve Homeostasis of Dendritic Cells

MLA

Chris A. Benedict, et al. “The Inhibitory HVEM-BTLA Pathway Counter Regulates Lymphotoxin β Receptor Signaling to Achieve Homeostasis of Dendritic Cells.” The Journal of Immunology, vol. 180, Jan. 2008, pp. 238–48. EBSCOhost, https://doi.org/10.4049/jimmunol.180.1.238.

APA

Chris A. Benedict, Kenneth M. Murphy, Nathalie Droin, Suk Won Ha, Kirsten Schneider, James Fulton, Paula S. Norris, Carl De Trez, Klaus Pfeffer, Carl F. Ware, Theresa L. Murphy, Karen G. Potter, & Yang Xin Fu. (2008). The Inhibitory HVEM-BTLA Pathway Counter Regulates Lymphotoxin β Receptor Signaling to Achieve Homeostasis of Dendritic Cells. The Journal of Immunology, 180, 238–248. https://doi.org/10.4049/jimmunol.180.1.238

Chicago

Chris A. Benedict, Kenneth M. Murphy, Nathalie Droin, Suk Won Ha, Kirsten Schneider, James Fulton, Paula S. Norris, et al. 2008. “The Inhibitory HVEM-BTLA Pathway Counter Regulates Lymphotoxin β Receptor Signaling to Achieve Homeostasis of Dendritic Cells.” The Journal of Immunology 180 (January): 238–48. doi:10.4049/jimmunol.180.1.238.